Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
Telomir Pharmaceuticals Inc. (NASDAQ : TELO) Stock
MWN-AI** Summary
MWN-AI** Analysis
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Description
Telomir Pharmaceuticals, Inc. is a pre-clinical-stage pharmaceutical company focused on the development and commercialization of TELOMIR-1, a novel small molecule being developed to function as an oralin situtherapeutic treatment for human stem cells. Its goal is to develop and commercialize new treatment options for age-related inflammatory conditions, with hemochromatosis as its initial clinical focus, and to thereafter expand the development of TELOMIR-1 to post-chemotherapy recovery as well as a broader range of other age-related inflammatory diseases and conditions such as osteoarthritis.
Quote
| Last: | $1.1502 |
|---|---|
| Change Percent: | -1.27% |
| Open: | $1.1437 |
| Close: | $1.165 |
| High: | $1.1691 |
| Low: | $1.14 |
| Volume: | 17,445 |
| Last Trade Date Time: | 09/16/2026 12:48:06 pm |
Stock Data
| Market Cap: | $40,225,736 |
|---|---|
| Float: | 20,889,878 |
| Insiders Ownership: | N/A |
| Institutions: | 14 |
| Short Percent: | N/A |
| Industry: | Biotechnology & Life Sciences |
| Sector: | Healthcare |
| Website: | https://www.telomirpharma.com |
| Country: | US |
| City: | Miami |
Recent News Releases
Subscribe to Our Newsletter
**MWN-AI FAQ is based on asking OpenAI questions about Telomir Pharmaceuticals Inc. (NASDAQ: TELO).
